Description
HEMOGLOBIN A1C CPRR TESTING
Base award description: IGF::OT::IGF HEMOGLOBIN A1C CPRR TESTING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-04-01+$115,200= $115,200
- Mod P000012020-07-20-$12,326= $102,874
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-04-01 | +$115,200 | $115,200 | IGF::OT::IGF HEMOGLOBIN A1C CPRR TESTING |
| Mod P00001· FUNDING ONLY ACTION | 2020-07-20 | −$12,326 | $102,874 | HEMOGLOBIN A1C CPRR TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KBN4ZDJ47ZB9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226N0092 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $7,824 | FY2026 |
| 36C25225P0899 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $200,000 | FY2025 |
| 36C24725P0688 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $36,977 | FY2025 |
| 36C24225C0040 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · J065 · MAINT/REPAIR/REBUILD OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | $32,800 | FY2025 |
| 36C24225N0202 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $7,824 | FY2025 |
| 36C25224P1125 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $189,668 | FY2024 |
Other recipients under 6630 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826F0134 | ROCHE DIAGNOSTICS CORPORATION | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $685,337 | FY2026 |
| 36C24826F0127 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $357,843 | FY2026 |
| 36C24826N0044 | BECKMAN COULTER, INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $346,465 | FY2026 |
| 36C24826N0034 | ABBOTT LABORATORIES INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $1,198,000 | FY2026 |
| 36C24826N0109 | ROCHE DIAGNOSTICS CORPORATION | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24819N0604_3600_VA24815A0014_3600 · retrieved 2026-09-25.